Chiron's PROLEUKIN ( Interleukin-2), the so-called Orphan Drug, which was recognized by the authorities of United States, Australia and other countries, has eventually started its clinical trials in China through PHDS’s assistance and effort. Currently, the clinical trials are going forward smoothly.